| Stanley C Marczyk, MD | |
|
24 Macarthur Blvd, Somers Point, NJ 08244-1776 | |
| (609) 927-1991 | |
| (609) 926-0075 |
| Full Name | Stanley C Marczyk |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 33 Years |
| Location | 24 Macarthur Blvd, Somers Point, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346356904 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atlanticare Regional Medical Center | Atlantic city, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shore Orthopaedic University Associates Pa | 1254308604 | 12 |
| Orthonj Llc | 6800225178 | 276 |
News Archive
New research shows that there are several interventions that could help prevent cognitive decline. According to the latest report entitled "Preventing Cognitive Decline and Dementia: A Way Forward," from the National Academies of Sciences, Engineering, and Medicine (NASEM), cognitive training, increase in physical activity, control of blood pressure adequately among those with a high blood pressure are all fruitful measures to reduce cognitive decline. However evidence to support these three interventions is encouraging but insufficient to justify a public health campaign focused on their adoption.
INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.
Lung cancer is the leading cause of cancer mortality in the United States, with a five-year survival rate of just 17 percent. Smoking causes approximately 85 percent of all lung cancer cases, only 15 percent of which are diagnosed at an early stage. Most efforts to obtain early diagnosis have been unsuccessful, largely due to the highly aggressive nature of the disease.
Investigators at St. Jude Children's Research Hospital settled a century-old debate on the origin of the mammalian lymphatic vasculature - the network of vessels and capillaries critical to various essential housekeeping functions in the body.
› Verified 3 days ago
| Entity Name | Shore Orthopaedic University Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114056900 PECOS PAC ID: 1254308604 Enrollment ID: O20040915000061 |
News Archive
New research shows that there are several interventions that could help prevent cognitive decline. According to the latest report entitled "Preventing Cognitive Decline and Dementia: A Way Forward," from the National Academies of Sciences, Engineering, and Medicine (NASEM), cognitive training, increase in physical activity, control of blood pressure adequately among those with a high blood pressure are all fruitful measures to reduce cognitive decline. However evidence to support these three interventions is encouraging but insufficient to justify a public health campaign focused on their adoption.
INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.
Lung cancer is the leading cause of cancer mortality in the United States, with a five-year survival rate of just 17 percent. Smoking causes approximately 85 percent of all lung cancer cases, only 15 percent of which are diagnosed at an early stage. Most efforts to obtain early diagnosis have been unsuccessful, largely due to the highly aggressive nature of the disease.
Investigators at St. Jude Children's Research Hospital settled a century-old debate on the origin of the mammalian lymphatic vasculature - the network of vessels and capillaries critical to various essential housekeeping functions in the body.
› Verified 3 days ago
| Entity Name | Orthonj Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720557432 PECOS PAC ID: 6800225178 Enrollment ID: O20200408000333 |
News Archive
New research shows that there are several interventions that could help prevent cognitive decline. According to the latest report entitled "Preventing Cognitive Decline and Dementia: A Way Forward," from the National Academies of Sciences, Engineering, and Medicine (NASEM), cognitive training, increase in physical activity, control of blood pressure adequately among those with a high blood pressure are all fruitful measures to reduce cognitive decline. However evidence to support these three interventions is encouraging but insufficient to justify a public health campaign focused on their adoption.
INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.
Lung cancer is the leading cause of cancer mortality in the United States, with a five-year survival rate of just 17 percent. Smoking causes approximately 85 percent of all lung cancer cases, only 15 percent of which are diagnosed at an early stage. Most efforts to obtain early diagnosis have been unsuccessful, largely due to the highly aggressive nature of the disease.
Investigators at St. Jude Children's Research Hospital settled a century-old debate on the origin of the mammalian lymphatic vasculature - the network of vessels and capillaries critical to various essential housekeeping functions in the body.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stanley C Marczyk, MD 24 Macarthur Blvd, Somers Point, NJ 08244-1776 Ph: (609) 927-1991 | Stanley C Marczyk, MD 24 Macarthur Blvd, Somers Point, NJ 08244-1776 Ph: (609) 927-1991 |
News Archive
New research shows that there are several interventions that could help prevent cognitive decline. According to the latest report entitled "Preventing Cognitive Decline and Dementia: A Way Forward," from the National Academies of Sciences, Engineering, and Medicine (NASEM), cognitive training, increase in physical activity, control of blood pressure adequately among those with a high blood pressure are all fruitful measures to reduce cognitive decline. However evidence to support these three interventions is encouraging but insufficient to justify a public health campaign focused on their adoption.
INSYS Therapeutics, Inc. announces positive results from the pivotal phase III efficacy trial for patients utilizing the Fentanyl Sublingual Spray technology to treat breakthrough cancer pain. All primary and secondary endpoints were achieved in the study, and the drug is the first product to ever show statistically significant pain relief when measuring the summary of pain intensity difference at five minutes in a phase III breakthrough cancer pain trial using Fentanyl.
Lung cancer is the leading cause of cancer mortality in the United States, with a five-year survival rate of just 17 percent. Smoking causes approximately 85 percent of all lung cancer cases, only 15 percent of which are diagnosed at an early stage. Most efforts to obtain early diagnosis have been unsuccessful, largely due to the highly aggressive nature of the disease.
Investigators at St. Jude Children's Research Hospital settled a century-old debate on the origin of the mammalian lymphatic vasculature - the network of vessels and capillaries critical to various essential housekeeping functions in the body.
› Verified 3 days ago
Dr. Kristen E Radcliff, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 415 New Rd Ste 3, Somers Point, NJ 08244 Phone: 609-800-3472 Fax: 609-800-3472 | |
David M Anapolle, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 547 New Rd, Somers Point, NJ 08244 Phone: 609-927-9200 Fax: 609-927-1616 | |
Richard Barnard Islinger, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Macarthur Blvd, Somers Point, NJ 08244 Phone: 609-927-1991 Fax: 609-926-0075 | |
Edward John Armbruster, D.O., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Macarthur Blvd, Somers Point, NJ 08244 Phone: 609-927-1991 Fax: 609-926-0075 | |
Dr. Jasmine Bauknight, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 710 Center St Fl 2, Somers Point, NJ 08244 Phone: 609-365-6280 | |
Mark Austin Pastore, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 24 Macarthur Blvd, Somers Point, NJ 08244 Phone: 609-927-1991 Fax: 609-926-0075 | |
Eugene John Demorat, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24 Macarthur Blvd, Somers Point, NJ 08244 Phone: 609-927-1991 Fax: 609-926-0075 |